SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  For example, here is how to disable FireFox ad content blocking while on Silicon Investor.
Biotech / Medical
Dyadic
An SI Board Since May 2011
Posts SubjectMarks Bans Symbol
9 1 0 DYIA
Emcee:  Paul Lee Type:  Unmoderated
Dyadic is a global biotechnology company focused on the discovery, development, manufacture and sale of enzyme and protein products for the biopharmaceutical, biofuels and industrial enzyme industries. Dyadic utilizes an integrated technology platform based on its patented and proprietary C1 fungus, which enables the development and large scale manufacture of low cost proteins and enzymes for diverse market opportunities. The C1 Platform Technology can also be used to screen for the discovery of novel genes and proteins. Dyadic actively pursues licensing arrangements and other commercial opportunities to leverage the value of these technologies by providing its partners and collaborators with the benefits of manufacturing and/or utilizing the enzymes which these technologies help produce. Please visit Dyadic’s website at www.dyadic.com.

Dyadic Netherlands is a wholly owned subsidiary of Dyadic based in Wageningen, The Netherlands that is dedicated to research and development activities for the benefit of Dyadic, its collaborators and customers. Please visit Dyadic Netherlands’ website at www.dyadic.nl.
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
914:01 04 Jun 2019 The biotechnology platform company helps drug makers negotiPaul Lee-June 4
8Dyadic International, Inc. Announces Research and Development Collaboration withPaul Lee-2/27/2018
7Dyadic International, Inc. Announces Research and Development Agreement to FurPaul Lee-9/7/2016
6DYADIC DEMONSTRATES INDUSTRY-LEADING BIOFUELS ENZYME PERFORMANCE AlternaFuelPaul Lee-7/16/2012
5DYADIC INTERNATIONAL PARTNERS WITH LEADING PROVIDER OF NUTRITIONAL INGREDIENT SOPaul Lee-2/29/2012
4DYADIC INTERNATIONAL ENTERS INTO RESEARCH AND LICENSE AGREEMENT WITH MAJOR PLAPaul Lee-6/27/2011
3Dyadic CEO makes a comeback Company sues prominent legal, accounting firms PrePaul Lee-5/7/2011
2Dyadic Netherlands Enters into R&D Collaboration with Sanofi Pasteur and EnGPaul Lee-5/7/2011
1The Best Growth Stock to Hold Forever (OTC: DYAI) Money — By Editor on November Paul Lee-5/7/2011
 Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):